The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Open accessAbstract
In response to oxidative stress, Nrf2 and p21(Cip1/WAF1) are both upregulated to protect cells from oxidative damage. Nrf2 is constantly ubiquitinated by a Keap1 dimer that interacts with a weak-binding (29)DLG motif and a strong-binding (79)ETGE motif in Nrf2, resulting in degradation of Nrf2. Modification of the redox-sensitive cysteine residues on Keap1 disrupts the Keap1-(29)DLG binding, leading to diminished Nrf2 ubiquitination and activation of the antioxidant response. However, the underlying mechanism by which p21 protects cells from oxidative damage remains unclear. Here we present molecular and genetic evidence suggesting that the antioxidant function of p21 is mediated through activation of Nrf2 by stabilizing the Nrf2 protein. The (154)KRR motif in p21 directly interacts with the (29)DLG and (79)ETGE motifs in Nrf2 and thus competes with Keap1 for Nrf2 binding, compromising ubiquitination of Nrf2. Furthermore, the physiological significance of our findings was demonstrated in vivo using p21-deficient mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 154KRR156 motif within p21 directly binds to the DLG and ETGE motifs in Nrf2, thereby competing with Keap1 for Nrf2 binding [26]; but instead of Nrf2 degradation, p21-Nrf2 binding leads to Nrf2 stabilization and increased response to oxidative stress [26].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Self-citationKeap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,284
Self-citationMcMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,105
Self-citationRamos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation
Kobayashi, M., & Yamamoto, M. P. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.385 · Cited by 1,087
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 640
Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer
Camiña, N., & Penning, T. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01642-0 · Cited by 49
The molecular biology and therapeutic potential of Nrf2 in leukemia
Khodakarami, A., Adibfar, S., Karpisheh, V., Abolhasani, S., Jalali, P., Mohammadi, H., Navashenaq, J. G., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02660-5 · Cited by 46
p21 as a Transcriptional Co-Repressor of S-Phase and Mitotic Control Genes
Ferrándiz, N., Caraballo, J. M., García-Gutiérrez, L., Devgan, V., Rodríguez‐Paredes, M., Lafita‐Navarro, M. C., Bretones, G., Quintanilla, A., Muñoz-Alonso, M. J., Blanco, R. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037759 · Cited by 48
Kim, J., Hwangbo, J., & Wong, P. K. Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016615 · Cited by 46
Sun, J., Wen, Y., Zhou, Y., Jiang, Y., Chen, Y., Zhang, H., Guan, L., Yao, X., Huang, M., & Bi, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0507-z · Cited by 44
Gu, X., Wang, Z., Gao, J., Han, D., Zhang, L., Chen, P., Luo, G., & Han, B. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.02.006 · Cited by 44
Obacunone activates the Nrf2-dependent antioxidant responses
Xu, S., Chen, W., Xie, Q., & Su, Z. (2016) · Protein & Cell · doi:10.1007/s13238-016-0297-y · Cited by 43
Self-citationNRF2 Rewires Cellular Metabolism to Support the Antioxidant Response
Lin, T.-Y., Cantley, L. C., & DeNicola, G. M. (2016) · InTech eBooks · doi:10.5772/65141 · Cited by 48
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion
Angeli, J. P. F., & Meierjohann, S. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12946 · Cited by 46
Kurosu, T., Wu, N., Oshikawa, G., Kagechika, H., & Miura, O. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0457-0 · Cited by 43
Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 45
Zhao, X., Zhang, J., Li, C., Kuang, W., Deng, J., Tan, X., Li, C., & Li, S. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101975 · Cited by 47
Kim, J. H., Xu, E. Y., Sacks, D. B., Lee, J. H., Shu, L., Xia, B., & Kong, A. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4586 · Cited by 42
Proteome Stability as a Key Factor of Genome Integrity
Gumeni, S., Evangelakou, Z., Gorgoulis, V. G., & Trougakos, I. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102036 · Cited by 44
Autophagy is involved in the protective effect of p21 on LPS-induced cardiac dysfunction
Huang, S., Xu, M., Liu, L., Yang, J., Wang, H., Wan, C., Deng, W., & Tang, Q. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02765-7 · Cited by 42
Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies
Farkhondeh, T., Pourbagher‐Shahri, A. M., Azimi–Nezhad, M., Forouzanfar, F., Brockmueller, A., Ashrafizadeh, M., Talebi, M., Shakibaei, M., & Samarghandian, S. (2021) · Molecules · doi:10.3390/molecules26113157 · Cited by 44
Vitamin E supplementation and mammalian lifespan
Banks, R., Speakman, J. R., & Selman, C. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900382 · Cited by 41
Liu, H., Zheng, S., Hou, G., Dai, J., Zhao, Y., Yang, F., Xiang, Z., Zhang, W., Wang, X., Gong, Y., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01414-2 · Cited by 40
Self-citationGarcia, T. Y., Gutierrez, M. A., Reynolds, J. C., & Lamba, D. A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17251 · Cited by 40
A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure
Bischoff, L. J. M., Kuijper, I. A., Schimming, J. P., Wolters, L., ter Braak, B., Langenberg, J. P., Noort, D., Beltman, J. B., & van de Water, B. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2353-2 · Cited by 40
Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure
Xu, P., Xi, Y., Wang, P., Luka, Z., Xu, M., Tung, H., Wang, J., Ren, S., Feng, D., Gao, B., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.12.260 · Cited by 40
Self-citationHuman GTSE-1 Regulates p21CIP1/WAF1 Stability Conferring Resistance to Paclitaxel Treatment
Bublik, D. R., Scolz, M., Triolo, G., Monte, M., & Schneider, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045948 · Cited by 40
Wang, X., Yang, J., Yang, W., Sheng, H., Jia, B., Peng, C., Xu, S., Hong, X., Jiang, C., Yang, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.10.026 · Cited by 46
Self-citationCytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2
Maiuthed, A., Ninsontia, C., Erlenbach‐Wuensch, K., Ndreshkjana, B., Muenzner, J. K., Caliskan, A., Husayn, A. P., Chaotham, C., Hartmann, A., Roehe, A. V., et al. (2018) · Cancers · doi:10.3390/cancers10100373 · Cited by 39
Role of chemopreventive phytochemicals in NRF2-mediated redox homeostasis in humans
Chun, K., Raut, P. K., Kim, D., & Surh, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.031 · Cited by 37
The dual role of p62 in ferroptosis of glioblastoma according to p53 status
Yuan, F., Sun, Q., Zhang, S., Ye, L., Xu, Y., Deng, G., Xu, Z., Zhang, S., Liu, B., & Chen, Q. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00764-z · Cited by 39
Habib, M. Z., Tadros, M. G., Abd-Alkhalek, H. A., Mohamad, M. I., Eid, D., Hassan, F. E., Elhelaly, H. M., el Faramawy, Y., & Aboul‐Fotouh, S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175046 · Cited by 38
Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication
Johar, R., Sharma, R., Kaur, A., & Mukherjee, T. K. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150518092315 · Cited by 39
Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Jhelum, P., Karisetty, B. C., Kumar, A., & Chakravarty, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666161213143907 · Cited by 38
Wang, S., Cao, K., Liao, Y. A., Zhang, W., Zheng, J., Li, X., Huang, M., Zhong, Y., Hu, X., Chen, D., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01855-w · Cited by 38
Seira, O., Kolehmainen, K., Liu, J., Streijger, F., Haegert, A. M., LeBihan, S., Boushel, R., & Tetzlaff, W. (2021) · Scientific Reports · doi:10.1038/s41598-021-96003-5 · Cited by 38
Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer
Hao, Q., Gan, Y., & Zhou, X. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01387-x · Cited by 43
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001
Ning, S., Sekar, T. V., Scicinski, J. J., Oronsky, B. T., Peehl, D. M., Knox, S. J., & Paulmurugan, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4249 · Cited by 37
Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors
Stadanlick, J. E., Zhang, Z., Lee, S.-Y., Hemann, M., Biery, M. C., Carleton, M. O., Zambetti, G. P., Anderson, S. J., Oravecz, T., & Wiest, D. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100029 · Cited by 36
Yeganeh, M., Gui, Y., Kandhi, R., Bobbala, D., Tobelaim, W.-S., Saucier, C., Yoshimura, A., Ferbeyre, G., Ramanathan, S., & Ilangumaran, S. (2016) · Oncogene · doi:10.1038/onc.2015.485 · Cited by 40
Dietary Flavonoids in p53—Mediated Immune Dysfunctions Linking to Cancer Prevention
Siddiqui, S. S., Rahman, S., Rupasinghe, H. P. V., & Vazhappilly, C. G. (2020) · Biomedicines · doi:10.3390/biomedicines8080286 · Cited by 36
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Fakheri, H., Sajadi, M. A., Afrashteh, A., Ma, W., Xia, L., & Valilo, M. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030504 · Cited by 40
Pereira, E. J., Burns, J. S., Lee, C. Y., Marohl, T., Calderon, D., Wang, L., Atkins, K. A., Wang, C., & Janes, K. A. (2020) · Science Signaling · doi:10.1126/scisignal.aba4200 · Cited by 36
Liu, R., Li, D., Sun, F., Rampoldi, A., Maxwell, J. T., Wu, R., Fischbach, P., Castellino, S. M., Du, Y., Fu, H., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01984-1 · Cited by 36
Lee, K.-M., Kang, K., Lee, S. B., & Nho, C. W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.053 · Cited by 36
Fetal origin confers radioresistance on liver macrophages via p21
Soysa, R., Lampert, S., Yuen, S. Y., Douglass, A. N., Li, W., Pfeffer, K., & Crispe, I. N. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.015 · Cited by 37
Kim, S., Saeidi, S., Cho, N., Kim, S. H., Lee, H., Han, W., Noh, D., & Surh, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.047 · Cited by 35
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way Forward
Fabrizio, F. P., Sparaneo, A., & Muscarella, L. A. (2020) · Cancers · doi:10.3390/cancers12123621 · Cited by 36
Iketani, M., Sekimoto, K., Igarashi, T., Takahashi, M. M., Komatsu, M., Sakane, I., Takahashi, H., Kawaguchi, H., Ohtani‐Kaneko, R., & Ohsawa, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-35239-0 · Cited by 35
Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer
Kang, J.-S., Nam, L. B., Yoo, O.-K., & Keum, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114002 · Cited by 35
Yoo, S.-H., Lim, Y., Kim, S.-J., Yoo, K.-D., Yoo, H., Hong, J. T., Lee, M.-Y., & Yun, Y. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.06.003 · Cited by 33
A role for p53 in mitochondrial stress response control of longevity in C. elegans
Torgovnick, A., Schiavi, A., Testi, R., & Ventura, N. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.007 · Cited by 33
Tolédano, M. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.005 · Cited by 33
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Mukherjee, A. G., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02124-4 · Cited by 33
Rau, T. F., Kothiwal, A., Rova, A. R., Brooks, D. M., Rhoderick, J. F., Poulsen, A., Hutchinson, J., & Poulsen, D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.001 · Cited by 34
Snouber, L. C., Jacques, S., Monge, M., Legallais, C., & Leclerc, É. (2012) · Genomics · doi:10.1016/j.ygeno.2012.05.001 · Cited by 32
Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice
Ghosh, S., Ihunnah, C. A., Hazra, R., Walker, A. L., Hansen, J. M., Archer, D. R., Owusu-Ansah, A. T., & Ofori-Acquah, S. F. (2016) · JCI Insight · doi:10.1172/jci.insight.81090 · Cited by 33
Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker? (Review)
Rodríguez, R. B. (2018) · Biomedical Reports · doi:10.3892/br.2018.1143 · Cited by 32
Garufi, A., Baldari, S., Pettinari, R., Montani, M. S. G., D’Orazi, V., Pistritto, G., Crispini, A., Giorno, E., Toietta, G., Marchetti, F., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01628-5 · Cited by 34
New derivatives of 4′-phenyl-2,2’:6′,2″-terpyridine as promising anticancer agents
Malarz, K., Zych, D., Gawecki, R., Kuczak, M., Musioł, R., & Mrozek‐Wilczkiewicz, A. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113032 · Cited by 32
Yan, W., Li, D., Chen, T., Tian, G., Zhou, P., & Ju, X. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00777 · Cited by 32
Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure
Hiemstra, S. W., Fehling-Kaschek, M., Kuijper, I. A., Bischoff, L. J. M., Wijaya, L. S., Rosenblatt, M., Esselink, J. J., van Egmond, A., Mos, J., Beltman, J. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10857-x · Cited by 31
Nrf2 expression in endometrial serous carcinomas and its precancers.
Chen, N., Yi, X., Abushahin, N., Pang, S., Zhang, D., Kong, B., & Zheng, W. (2010) · PubMed Central · Cited by 31
Self-citationRETRACTED ARTICLE: Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer
Xu, C., Wang, X., Zhou, Y., Chen, F., Wang, H., Li, K., Fan, H., Tang, X., Jiang, G., & Zhang, J. (2019) · Oncogene · doi:10.1038/s41388-019-0930-3 · Cited by 30
Self-citationRetractedGatti, M., Beretti, F., Zavatti, M., Bertucci, E., Luz, S. R., Palumbo, C., & Maraldi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010038 · Cited by 30
Garufi, A., Pistritto, G., D’Orazi, V., Cirone, M., & D’Orazi, G. (2022) · Biomolecules · doi:10.3390/biom12030461 · Cited by 29
Joo, M. S., Shin, S., Kim, E., Koo, H. J., Yim, H., & Kim, S. G. (2019) · The FASEB Journal · doi:10.1096/fj.201802744r · Cited by 30
Cullin 3 and Its Role in Tumorigenesis
Chen, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_12 · Cited by 29
Hiemstra, S. W., Niemeijer, M., Koedoot, E., Wink, S., Klip, J. E., Vlasveld, M., de Zeeuw, E., van Os, B. W., White, A., & van de Water, B. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00322 · Cited by 31
Familial Melanoma–Associated Mutations in p16 Uncouple its Tumor-Suppressor Functions
Jenkins, N., Jung, J., Liu, T., Wilde, M., Holmen, S. L., & Grossman, D. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.401 · Cited by 31
Carvalho, C. S. C., da Silva, R. D. F., Melo, T. M. V. D. P. E., Inga, A., & Saraiva, L. (2024) · Cancers · doi:10.3390/cancers16233978 · Cited by 32
CDDO and Its Role in Chronic Diseases
Mathis, B. J., & Cui, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41342-6_13 · Cited by 28
Beeraka, N. M., Bovilla, V. R., Doreswamy, S. H., Puttalingaiah, S., Srinivasan, A., & Madhunapantula, S. V. (2021) · Cancers · doi:10.3390/cancers13020281 · Cited by 28
The antioxidant response in Barrett's tumorigenesis: A double-edged sword
Peng, D., Zaika, A. I., Que, J., & El-Rifai, W. M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101894 · Cited by 28
Boda, E., Lorenzati, M., Parolisi, R., Harding, B. N., Pallavicini, G., Bonfanti, L., Moccia, A., Bielas, S. L., Cunto, F. D., & Buffo, A. (2022) · Nature Communications · doi:10.1038/s41467-022-30010-6 · Cited by 31
Maher, T. J., Ren, Y., Li, Q., Braunlin, E., Garry, M. G., Sorrentino, B. P., & Martin, C. M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00638.2013 · Cited by 28
Hepatic Transcriptome Responses of Domesticated and Wild Turkey Embryos to Aflatoxin B1
Monson, M. S., Cardona, C. J., Coulombe, R. A., & Reed, K. M. (2016) · Toxins · doi:10.3390/toxins8010016 · Cited by 28
Izumi, Y., & Kōyama, Y. (2024) · Antioxidants · doi:10.3390/antiox13121527 · Cited by 31
Ito, T., Kimura, S., Seto, K., Warabi, E., Kawachi, Y., Shoda, J., Tabuchi, K., Yamagata, K., Hasegawa, S., Bukawa, H., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.12.002 · Cited by 27
Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity
Murray, D. L., Mirzayans, R., & McBride, W. H. (2018) · Radiation Research · doi:10.1667/rr15101.1 · Cited by 28
Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
Deen, A. J., Adinolfi, S., Härkönen, J., Patinen, T., Liu, X., Laitinen, T., Takabe, P., Kainulainen, K., Pasonen-Seppänen, S., Gawriyski, L. M., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103031 · Cited by 27
Singlet-oxygen-derived products from linoleate activate Nrf2 signaling in skin cells
Ogawa, Y., Shichiri, M., Nishio, K., Yoshida, Y., Niki, E., & Hagihara, Y. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.004 · Cited by 27
Wan, Z., Jiang, T., Shi, Y., Pan, Y., Lin, Y., Ma, Y., Yang, C., Feng, X., Huang, L., Kong, X., et al. (2019) · Hepatology · doi:10.1002/hep.30962 · Cited by 27
Self-citationShilovsky, G. A., & Dibrova, D. V. (2023) · Life · doi:10.3390/life13041045 · Cited by 27
Peng, D., Lu, H., Zhu, S., Zhou, Z., Hu, T., Chen, Z., Zaika, A. I., & El-Rifai, W. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.031 · Cited by 26
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
Brackhan, M., Arribas-Blázquez, M., & Lastres‐Becker, I. (2023) · Antioxidants · doi:10.3390/antiox12081564 · Cited by 28
Uncovering metabolism in rhabdomyosarcoma
Monti, E., & Fanzani, A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1071746 · Cited by 26
Kim, E. H., Jang, H.-J., & Roh, J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0332 · Cited by 26
Dietary restriction and aging in rodents: a current view on its molecular mechanisms.
Shimokawa, I., & Trindade, L. S. (2010) · Europe PMC (PubMed Central) · Cited by 26
Hasan, S. K., Jayakumar, S., Barroso, E. E., Jha, A., Catalano, G., Sandur, S. K., & Noguera, N. I. (2025) · Cells · doi:10.3390/cells14100713 · Cited by 31
Datta, S., & Sinha, D. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103553 · Cited by 25
Involvement of the p62/Nrf2/HO-1 pathway in the browning effect of irisin in 3T3-L1 adipocytes
Tsai, Y.-C., Wang, C.-W., Wen, B.-Y., Hsieh, P., Lee, Y., Yen, M., & Cheng, P. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110915 · Cited by 25
Hwang, S., Yang, Y., Jung, J., & Kim, Y. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02824-3 · Cited by 29
Xiao, H., Lu, F.-L., Stewart, D., & Zhang, Y. (2013) · Current Chemical Biology · doi:10.2174/2212796811307020008 · Cited by 25
Han, D., Gao, J., Gu, X., Hengstler, J. G., Zhang, L., Shahid, M. S., Ali, T., & Han, B. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2070-2 · Cited by 24
Johnson, A. C. M., & Zager, R. A. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy029 · Cited by 24
Zhang, H., Chen, Y., Xu, R., & He, Q. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.21 · Cited by 24
Jiang, J., Tam, L. M., Wang, P., & Wang, Y. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00062 · Cited by 24
Lastra, D., Escoll, M., & Cuadrado, A. (2022) · Antioxidants · doi:10.3390/antiox11050946 · Cited by 24
Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer
Wu, W., Zhao, Y., Qin, B., Jiang, X. M., Wang, C., Hu, R., Ma, R., Lee, M., Liu, H., Li, K., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104650 · Cited by 28
Protective Effects of L‐Malate against Myocardial Ischemia/Reperfusion Injury in Rats
Ding, S., Yang, Y., & Mei, J. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3803657 · Cited by 24
Soltani, B., Ghaemi, N., Sadeghizadeh, M., & Najafi, F. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.07.021 · Cited by 24
Kumar, B., Roy, A., Asha, K., Sharma-Walia, N., Ansari, M. A., & Chandran, B. (2019) · Journal of Virology · doi:10.1128/jvi.01812-18 · Cited by 23
Poornima, P., Kankia, I. H., Langdon, S. P., & Deeni, Y. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.57 · Cited by 24
Harvey, S. A. K., Guerriero, E., Charukamnoetkanok, N., Piluek, J., Schuman, J. S., & SundarRaj, N. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4498 · Cited by 24
Metadata
- Authors
- Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D.
- Affiliations
- University of Arizona (US)
- University of Missouri (US)
- Corresponding author
- Zhang, Donna D.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 34
- Issue
- 6
- Pages
- 663-673
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC2714804
- OpenAlex
- W2080155284
- Cited by
- 638
- References
- 36
- Citations by year
- 2026: 24 · 2025: 15 · 2024: 50 · 2023: 31 · 2022: 43 · 2021: 51 · 2020: 48 · 2019: 52 · 2018: 48 · 2017: 35 · 2016: 44 · 2015: 29 · 2014: 40 · 2013: 38 · 2012: 34
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1543 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (ES006694, RSG-07-154)
- National Institute of Environmental Health Sciences (ES015010)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, p21, Keap1, oxidative stress, antioxidant response, protein stabilization, ubiquitination, protein-protein interaction
- MeSH terms
- Animals, Antioxidants, Binding Sites, Male, Up-Regulation, Oxidative Stress, Amino Acid Motifs, Cyclin-Dependent Kinase Inhibitor p21, NF-E2-Related Factor 2, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review